Type 2 chronic inflammatory diseases: targets, therapies and unmet needs

P Kolkhir, CA Akdis, M Akdis, C Bachert… - Nature Reviews Drug …, 2023 - nature.com
Over the past two decades, significant progress in understanding of the pathogenesis of type
2 chronic inflammatory diseases has enabled the identification of compounds for more than …

Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances

A Kaplan, M Lebwohl, AM Giménez‐Arnau, M Hide… - Allergy, 2023 - Wiley Online Library
Chronic spontaneous urticaria (CSU) is a debilitating skin disease characterized by
intensely itchy wheals, angioedema, or both. Symptoms recur spontaneously, on a near …

Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases

M Metz, P Kolkhir, S Altrichter, F Siebenhaar… - Allergy, 2024 - Wiley Online Library
Chronic urticaria (CU) is a mast cell (MC)‐dependent disease with limited therapeutic
options. Current management strategies are directed at inhibiting IgE‐mediated activation of …

A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis

RV Suresh, C Dunnam, D Vaidya… - The Journal of …, 2023 - Am Soc Clin Investig
BACKGROUND IgE-mediated anaphylaxis is a potentially fatal systemic allergic reaction for
which there are no currently FDA-approved preventative therapies. Bruton's tyrosine kinase …

Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment

T Zuberbier, LF Ensina, A Giménez-Arnau, C Grattan… - The Lancet, 2024 - thelancet.com
Chronic urticaria is a common and debilitating mast cell-driven skin disease presenting with
itchy wheals, angio-oedema, or both. Chronic urticaria is classified as spontaneous (without …

Urticaria and angioedema: understanding complex pathomechanisms to facilitate patient communication, disease management, and future treatment

GN Konstantinou, MA Riedl, P Valent, I Podder… - The Journal of Allergy …, 2023 - Elsevier
Chronic spontaneous urticaria (CSU) is primarily a T2-dominant disease with a complex
genetic background. Skin mast cell activation can be induced not only via the IgE-FcεRI axis …

[HTML][HTML] BTK signaling—a crucial link in the pathophysiology of chronic spontaneous urticaria

JA Bernstein, M Maurer, SS Saini - Journal of Allergy and Clinical …, 2024 - Elsevier
Chronic spontaneous urticaria (CSU) is an inflammatory skin disorder that manifests with
itchy wheals, angioedema, or both for more than 6 weeks. Mast cells and basophils are the …

Current and emerging therapies for chronic spontaneous urticaria: a narrative review

G Yosipovitch, G Biazus Soares, O Mahmoud - Dermatology and therapy, 2023 - Springer
Chronic spontaneous urticaria (CSU) is a condition in which wheals, angioedema, and
pruritus occur spontaneously and recurrently for at least 6 weeks. The etiology of this …

New insights into chronic inducible urticaria

M Muñoz, LA Kiefer, MP Pereira, M Bizjak… - Current Allergy and …, 2024 - Springer
Abstract Purpose of Review Chronic inducible urticaria (CIndU) is a group of long-persisting
and challenging to manage diseases, characterized by recurrent wheals and angioedema …

Chronic Spontaneous Urticaria: A Review

P Kolkhir, H Bonnekoh, M Metz, M Maurer - JAMA, 2024 - jamanetwork.com
Importance Chronic spontaneous urticaria affects approximately 1% of the general
population worldwide, including approximately 3 million people in the US, impairs patients' …